Dr. Paul Brunetta co-founded the UCSF Fontana Tobacco Treatment Center, which helps people quit smoking through classes as well as individual consultations with specialists in tobacco addiction.
Brunetta also serves as a principal medical director at Genentech within global product development in immunology.
One focus of Brunetta's research is on developing novel therapies for immunologic disease. He also looks at improved evaluations and drug approvals for rare diseases, such as anti-neutrophil cytoplasmic antibody-associated vasculitis.
Brunetta earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at UCSF. He was a medical chief resident at Zuckerberg San Francisco General Hospital and Trauma Center before completing a pulmonary and critical care fellowship at UCSF.
Tufts University, 1990
UCSF, Internal Medicine, 1993
UCSF, Pulmonary and Critical Care Medicine, 1998